These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. The new generation of hepatocellular markers. Mount S Cancer Cytopathol; 2012 Aug; 120(4):217-9. PubMed ID: 22760992 [No Abstract] [Full Text] [Related]
68. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668 [TBL] [Abstract][Full Text] [Related]
69. Hepatocellular carcinoma: paving the road for further developments. Bruix J Semin Liver Dis; 2014 Nov; 34(4):361. PubMed ID: 25369298 [No Abstract] [Full Text] [Related]
70. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations. Rivenbark AG; Coleman WB Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087 [No Abstract] [Full Text] [Related]
71. Use of common seric tumor markers in patients with solid cancers. Gara S; Boussen H; Ghanem A; Guemira F Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452 [TBL] [Abstract][Full Text] [Related]
74. Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC). Murakami N; Tamano M; Yoneda M; Sugaya H; Hiraishi H Hepatogastroenterology; 2008; 55(81):197-201. PubMed ID: 18507106 [TBL] [Abstract][Full Text] [Related]
75. Alpha feto-protein in the diagnosis of primary hepatocarcinoma in Salisbury. Ashworth TG Cent Afr J Med; 1974 Jan; 20(1):5-7. PubMed ID: 4376463 [No Abstract] [Full Text] [Related]
76. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271 [TBL] [Abstract][Full Text] [Related]
77. A fetal serum protein in a new role. N Engl J Med; 1968 May; 278(18):1016. PubMed ID: 4171302 [No Abstract] [Full Text] [Related]
78. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma]. Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882 [TBL] [Abstract][Full Text] [Related]
79. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma. Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331 [TBL] [Abstract][Full Text] [Related]
80. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]